Catapano, Alberico L.
Lee, L. Veronica
Louie, Michael J.
Thompson, Desmond
Bergeron, Jean
Krempf, Michel
Article History
Received: 27 January 2017
Accepted: 1 March 2017
First Online: 4 April 2017
Competing interests
: A.L. Catapano: research grants to institution from Amgen, AstraZeneca, Daiichi-Sankyo, Genentech/F. Hoffman La Roche, GlaxoSmithKline, Merck, Regeneron Pharmaceuticals, Inc./Sanofi, and Sigma Tau; consultant/lectures for Aegerion, Amgen, Boehringer Ingelheim, Doc Generici, Genzyme/Ionis, Merck, Pfizer, Roche, Sanofi, and Sigma Tau. L.V. Lee: employee of and stockholder in Sanofi. M.J. Louie and D. Thompson: employees of and stockholders in Regeneron Pharmaceuticals, Inc. J. Bergeron: consultant/advisory board and speaker fees from Amgen, Aegerion, and Sanofi. M. Krempf: research grants from Amgen, Merck, Regeneron Pharmaceuticals, Inc., Sanofi, and Ionis; speaker fees and advisory boards for Amgen, Sanofi, and Regeneron Pharmaceuticals, Inc.